Despite major breakthroughs in HIV prevention and treatment, there were an estimated 1.8 million people newly infected with HIV in
Cross-clade immune responses reported in South African RV144 HIV vaccine regimen
Home »
One-month regimen noninferior for preventing HIV-related TB
(HealthDay)—For HIV-infected patients, a one-month regimen of rifapentine and isoniazid is noninferior to nine months of isoniazid alone for preventing